Cardiolipin, the Mitochondrial Signature Lipid: Implication in Cancer
Round 1
Reviewer 1 Report
The manuscript is a ontime revision of the cardiolipin relevant findings. This findings are necessary for the management of future therapies that target mitochondrial signalling pathways in cancer patients. The work is well organised, the reference are up to date, but need some corection. The english language needs some minor spelling correction.
Author Response
Please see the attachment.
Author Response File:
Author Response.pdf
Reviewer 2 Report
Please see attached report
Comments for author File:
Comments.pdf
Author Response
Please see the attachment.
Author Response File:
Author Response.pdf
